Scientific Reviews
Product Guides
Blogs
Topics
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!2025-02-06
32 Results for "
CD31
" in MedChemExpress (MCE) Product Catalog:
Products (32)
32 Results for "CD31" in MCE Product Catalog:
3
3 Cited Publications
Cat. No.: HY-P80447
Synonyms: Adhesion molecule antibody;
CD31 antibody;
CD31 antigen antibody;
CD31 EndoCAM antibody;
EndoCAM antibody;
FLJ34100 antibody;
FLJ58394 antibody;
GPIIA antibody;
GPIIA' antibody;
PECA1 antibody;
PECA1_HUMAN antibody;
Pecam 1 antibody;
PECAM 1 CD31 EndoCAM antibody;
PECAM antibody;
PECAM-1 antibody;
Pecam1 antibody;
Platelet and endothelial cell adhesion molecule 1 antibody;
Platelet endothelial cell adhesion molecule antibody;
Platelet/endothelial cell adhesion molecule 1 antibody;
1
1
1
Cat. No.: HY-P3325
CAS No.: 2147724-76-1
Synonyms: D-P8RI
Target:
Research Areas:
Target:
Cat. No.: HY-P990277
Target:
Research Areas:
Cat. No.: HY-P3444
CAS No.: 161374-99-8
Synonyms: PECAM-1
Research Areas:
Target:
Research Areas:
Neamine tetrahydrochloride, a degradation product of Neomycin, is a broad-spectrum aminoglycoside antibiotic. Neamine tetrahydrochloride is an anti-angiogenesis agent targeting angiogenin. Neamine tetrahydrochloride has potent antibacterial, antitumor and neuroprotective activities .
Cat. No.: HY-P3444A
Synonyms: PECAM-1 TFA
Research Areas:
Cat. No.: HY-W777599
CAS No.: 1216704-11-8
Synonyms: (Rac)-Naproxen-13C,d3-1
Cat. No.: HY-156077
CAS No.: 2422001-22-5
Target:
Research Areas:
anti-TNBC agent-2 (3j) an anti-Triple negative breast cancer (TNBC) purine derivative. anti-TNBC agent-2 induces MDA-MB-231 cells apoptosis, and inhibits its migration and angiogenesis. anti-TNBC agent-2 inhibits tumor growth and metastasis and reduces the expression of Ki67 and CD31 protein in TNBC xenograft models. anti-TNBC agent-2 can be used for Triple negative breast cancer (TNBC) research .
Target:
Research Areas:
Infection Cardiovascular Disease Neurological Disease Cancer
Neamine, a degradation product of Neomycin, is a broad-spectrum aminoglycoside antibiotic. Neamine is an anti-angiogenesis agent targeting angiogenin. Neamine has potent antibacterial, antitumor and neuroprotective activities .
Cat. No.: HY-117991
CAS No.: 1804982-31-7
DW10075 is a highly selective and orally active VEGFR inhibitor targeting the VEGF/VEGFR pathway. DW10075 selectively inhibits VEGFR-1, VEGFR-2, and VEGFR-3, but has no effect on FGFR and PDGFR. DW10075 inhibits VEGF-induced HUVEC proliferation, migration, and tube formation. And DW10075 inhibits angiogenesis in both the rat aortic ring model and the chick chorionic membrane model. DW10075 also exhibits antiproliferative activity against human cancer cell lines, with IC50s of 2.2 μM and 22.2 μM against U87-MG human glioblastoma cells and A375 melanoma cells, respectively. In the nude mouse U87-MG xenograft tumor model, DW10075 (po) significantly inhibits tumor growth and reduces the expression of CD31 and Ki67 in tumor tissues.
Cat. No.: HY-P700675
Purity: ≥ 95%, as determined by reducing SDS-PAGE.
Synonyms: PECAM-1; EndoCAM; PECA1; CD31; FLJ34100; FLJ58394; GPIIA'
Species:
Source:
- 1
- 2
-
-
Protocols
Targeted therapy! The Capetin Prize winning "Click Chemistry" can be used like this!Targeted therapy! The Nobel Prize winning "Click Chemistry" can be used like this!A suitable model is crucial in drug screening experiments. Organs can mimic the three-dimensional functional structure of internal organs, have similar spatial organization to corresponding organs, maintain some key characteristics, and reproduce some physiological functions. They are widely used for modeling and personalized drug screening physiological functions.2025-02-06
